Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504

被引:259
作者
Hu, Wenwei [1 ]
Chan, Chang S. [2 ]
Wu, Rui [1 ]
Zhang, Cen [1 ]
Sun, Yvonne [1 ]
Song, Jun S. [2 ]
Tang, Laura H. [3 ]
Levine, Arnold J. [1 ,2 ]
Feng, Zhaohui [1 ]
机构
[1] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
SINGLE NUCLEOTIDE POLYMORPHISM; GENOMIC REGIONS; GENE; CELL; EXPRESSION; TARGET; PATHWAY; AMPLIFICATION; SPECIFICITY; ACTIVATION;
D O I
10.1016/j.molcel.2010.05.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor p53 plays a central role in tumor prevention. p53 protein levels and activity are under a tight and complex regulation in cells to maintain the proper function of p53. MicroRNAs play a key role in the regulation of gene expression. Here we report the regulation of p53 through miR-504. miR-504 acts as a negative regulator of human p53 through its direct binding to two sites in the p53 3' untranslated region. Overexpression of miR-504 decreases p53 protein levels and functions in cells, including p53 transcriptional activity, p53-mediated apoptosis, and cell-cycle arrest in response to stress, and furthermore promotes tumorigenecity of cells in vivo. These results demonstrate the direct negative regulation of p53 by miR-504 as a mechanism for p53 regulation in cells, which highlights the importance of microRNAs in tumorigenesis.
引用
收藏
页码:689 / 699
页数:11
相关论文
共 44 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]  
Bennett WP, 1999, J PATHOL, V187, P8, DOI 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO
[3]  
2-Y
[4]   Identification of hundreds of conserved and nonconserved human microRNAs [J].
Bentwich, I ;
Avniel, A ;
Karov, Y ;
Aharonov, R ;
Gilad, S ;
Barad, O ;
Barzilai, A ;
Einat, P ;
Einav, U ;
Meiri, E ;
Sharon, E ;
Spector, Y ;
Bentwich, Z .
NATURE GENETICS, 2005, 37 (07) :766-770
[5]   p53-mediated activation of miRNA34 candidate tumor-suppressor genes [J].
Bommer, Guido T. ;
Gerin, Isabelle ;
Feng, Ying ;
Kaczorowski, Andrew J. ;
Kuick, Rork ;
Love, Robert E. ;
Zhai, Yali ;
Giordano, Thomas J. ;
Qin, Zhaohui S. ;
Moore, Bethany B. ;
MacDougald, Ormond A. ;
Cho, Kathleen R. ;
Fearon, Eric R. .
CURRENT BIOLOGY, 2007, 17 (15) :1298-1307
[6]   A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].
Bond, GL ;
Hu, WW ;
Bond, EE ;
Robins, H ;
Lutzker, SG ;
Arva, NC ;
Bargonetti, J ;
Bartel, F ;
Taubert, H ;
Wuerl, P ;
Onel, K ;
Yip, L ;
Hwang, SJ ;
Strong, LC ;
Lozano, G ;
Levine, AJ .
CELL, 2004, 119 (05) :591-602
[7]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[8]   Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth [J].
Buzzai, Monica ;
Jones, Russell G. ;
Amaravadi, Ravi K. ;
Lum, Julian J. ;
DeBerardinis, Ralph J. ;
Zhao, Fangping ;
Viollet, Benoit ;
Thompson, Craig B. .
CANCER RESEARCH, 2007, 67 (14) :6745-6752
[9]   Sizing up miRNAs as cancer genes [J].
Caldas, C ;
Brenton, JD .
NATURE MEDICINE, 2005, 11 (07) :712-714
[10]   Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J].
Calin, GA ;
Sevignani, C ;
Dan Dumitru, C ;
Hyslop, T ;
Noch, E ;
Yendamuri, S ;
Shimizu, M ;
Rattan, S ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2999-3004